ObjectiveTo investigate the clinical efficacy and safety of carvedilol in the treatment of arrhythmia in patients with hypertension complicated with diabetes mellitus. MethodsWe selected the patients with hypertension complicated with diabetes mellitus who were hospitalized in the Harrison International Peace Hospital Affiliated to Hebei Medical University for treatment from Oct. 2011 to Oct. 2013. The cases were divided into a trial group and a control group. The control group was given routine treatment (eg., hypoglycaemic drugs, angiotensin converting enzyme inhibitors). On the basis of the same treatment of the control group, the trial group was given carvedilol. The efficacy and adverse reaction were observed, recorded and then analyzed between the two groups. ResultsA total of 140 patients were included (70 cases in each group). With the loss of 10 cases in the control group, the data of 70 cases in the trial group and 60 cases in the control group were finally analyzed. The results showed that the trial group was superior to the control group in the total effectiveness (χ2=8.320, P=0.004) and the dynamic ECG improvement of premature ventricular contraction (χ2=5.333, P=0.014) with significant differences. Both groups were significantly improved in blood pressure and heart beats compared with the situation before treatment (Both P < 0.05), and the trial group was better than the control group with a significant difference. During the treatment, three cases in the trial group had mild gastrointestinal symptoms which spontaneously disappeared later. ConclusionThe clinical effectiveness of carvedilol for arrhythmia in patients with hypertension complicated with diabetes mellitus is significant. It is safe and effective which is recommended in clinical application.
Objective To investigate the risky factors of ventricular arrhythmias following open heart surgery in patients with giant left ventricle, and offer the basis in order to prevent it’s occurrence. Methods The clinical materials of 176 patients who had undergone the open heart surgery were analyzed retrospectively. There were 44 patients who had ventricular arrhythmia (ventricular arrhythmia group), 132 patients who had no ventricular arrhythmia as contrast (control group). The preoperative clinical data, indexes of types of cardiopathy, ultrasonic cardiogram, electrocardiogram and cardiopulmonary bypass (CPB) etc. were choosed, and tested by using χ2 test,t test and logistic regression to analyse the high endangered factors for incidence of ventricular arrhythmia after open heart surgery. Results Age≥55 years (OR=3.469), left ventricular enddiastolic diameter(LVEDD)≥80 mm (OR=3.927), left ventricular ejection fraction（LVEF）≤55% (OR=2.967), CPB time≥120min(OR=5.170) and aortic clamping time≥80min(OR=4.501) were the independent risk factors of ventricular arrhythmia. Conclusion Ventricular arrhythmia is a severe complication for the patients with giant left ventricle after open heart surgery, and influence the prognosis of the patients. Patient’s age, size of the left ventricle, cardiac function, CPB time and clamping time could influence the incidence of ventricular arrhythmias.
Objective To analyze the risk factors affecting the occurrence of arrhythmia after esophageal cancer surgery, construct a risk prediction model, and explore its clinical value. Methods A retrospective analysis was conducted on the clinical data of patients who underwent radical esophagectomy for esophageal cancer in the Department of Thoracic Surgery at Anhui Provincial Hospital from 2020 to 2023. Univariate and multivariate analyses were used to screen potential factors influencing postoperative arrhythmia. A risk prediction model for postoperative arrhythmia was constructed, and a nomogram was drawn. The predictive performance of the model was then validated. Results A total of 601 esophageal cancer patients were randomly divided into a modeling group (421 patients) and a validation group (180 patients) at a 7 : 3 ratio. In the modeling group, patients were further categorized into an arrhythmia group (188 patients, 44.7%) and a non-arrhythmia group (233 patients, 55.3%) based on whether they developed postoperative arrhythmia. Among those with postoperative arrhythmia, 43 (10.2%) patients had atrial fibrillation (AF), 12 (2.9%) patients had atrial premature beats, 15 (3.6%) patients had sinus bradycardia, and 143 (34%) patients had sinus tachycardia. Some patients exhibited multiple arrhythmias, including 14 patients with AF combined with sinus tachycardia, 7 patients with AF combined with atrial premature beats, and 3 patients with AF combined with sinus bradycardia. Univariate analysis revealed that a history of hypertension, heart disease, pulmonary infection, acute respiratory distress syndrome, postoperative hypoxia, anastomotic leakage, and delirium were risk factors for postoperative arrhythmia in esophageal cancer patients (P<0.05). Multivariate logistic regression analysis showed that a history of heart disease, pulmonary infection, and postoperative hypoxia were independent risk factors for postoperative arrhythmia after esophageal cancer surgery (P<0.05). The area under the receiver operating characteristic curve (AUC) of the constructed risk prediction model for postoperative arrhythmia was 0.710 [95% CI (0.659, 0.760)], with a sensitivity of 0.617 and a specificity of 0.768. Conclusion A history of heart disease, pulmonary infection, and postoperative hypoxia are independent risk factors for postoperative arrhythmia after esophageal cancer surgery. The risk prediction model constructed in this study can effectively identify high-risk patients for postoperative arrhythmia, providing a basis for personalized interventions.
ObjectiveTo compare the effectiveness of different β-blockers for preventing postoperative atrial fibrillation (POAF) after cardiac surgery. Methods Databases of PubMed, Science Direct, Web of Science, The Cochrane Library, SinoMed, CKNI, VIP, WanFang were searched by the computer from inception to April 31, 2022 to collect randomized controlled studies on the comparison of the effectiveness of different β-blockers for preventing POAF. Two investigators independently screened the literature and extracted information. The quality of the literature was evaluated using Cochrane bias risk tool, and RevMan 5.3 and STATA 17.0 were used for meta-analysis. Results A total of 17 randomized controlled studies with 3 290 patients were included. Direct meta-analysis showed that landiolol and metoprolol were more effective than placebo (P≤0.001), and carvedilol was more effective than metoprolol in preventing the development of POAF (P<0.001). Network meta-analysis showed that landiolol, carvedilol and metoprolol were more effective than placebo in preventing the incidence of POAF (P<0.05). Landiolol and carvedilol were more effective than metoprolol, and carvedilol were more effective than nebivolol (P<0.05). The surface under the cumulative ranking curve from high to low were carvedilol, landilol, propranolol, atenolol, metoprolol, and nebivolol. Conclusion Carvedilol and landilol have different degrees of improvement in the occurrence of POAF, and carvedilol has the best preventive effect. More studies are required to verify the strength of evidence due to the limited sample size.